13F filing recap · Q3 2024

What did Baupost Group LLC buy in Q3 2024?

Reported stock-position changes between this filing and the previous one.

Stock value

$3.50B

Positions

Estimated turnover

39.0%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

Quarter in review

Baupost Group initiated positions in Dollar General, Liberty Broadband, Tamboran Resources, and Restaurant Brands International. The firm exited Humana, Liberty Media, VeriSign, Willscot Holdings, Capri Holdings, Jazz Pharmaceuticals, and Theravance Biopharma. It substantially added to Alphabet, Wesco International, and Eagle Materials, while substantially trimming Crh Public Limited Company and Fidelity National Information Services. It also modestly increased Willis Towers Watson and moderately reduced Viasat, Jacobs Solutions, and Fortrea Holdings.

New positions

DGDollar General Corp$194.83Mreported value+2.30M shares LBRDKLiberty Broadband Corporation$13.19Mreported value+170.6K shares TBNTamboran Resources Corporation$11.60Mreported value+570.8K shares QSRRestaurant Brands International Inc.$2.04Mreported value+28.3K shares

Increased positions

WTWWillis Towers Watson Plc$524.62Mreported value+128.6K shares+7.8%GOOGAlphabet Inc.$245.03Mreported value+396.0K shares+37.0%WCCWesco International, Inc.$211.32Mreported value+455.0K shares+56.7%EXPEagle Materials Inc.$143.90Mreported value+158.2K shares

Reduced positions

CRHCrh Public Limited Company$244.52Mreported value-1.59M shares-37.6%VSATViasat, Inc.$145.94Mreported value-1.54M shares-11.2%FISFidelity National Information Services, Inc.$81.36Mreported value-2.54M shares-72.3%JJacobs Solutions Inc.$45.90Mreported value-143.5K shares

Exited positions

HUMHumana Inc$156.93Mprior reported value-420.0K shares-100.0%JAZZJazz Pharmaceuticals Plc$136.00Mprior reported value-1.27M shares-100.0%WSCWillscot Holdings Corporation$92.97Mprior reported value-2.47M shares-100.0%TBPHTheravance Biopharma, Inc.$35.62Mprior reported value-4.20M shares